Active substance
Atenolol
- SFDA 39
- US FDA 32
- Health Canada 28
- US price lines 4
- NHS prices 4
- WHO EML 1
- Safety 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| BETATEN 100MG F.C. TABS | 100 mg | Film-coated tablet · Oral use | 28 Blister | SAR 18.50 | Generic · Prescription | National Pharmaceutical Industries Co. (SAOG) | Valid |
| BETATEN 25MG F.C. TABLETS | 25 mg | Film-coated tablet · Oral use | 28 Blister | SAR 6.65 | Generic · Prescription | National Pharmaceutical Industries Co. (SAOG) | Valid |
| BETATEN 50MG F.C.TABLET | 50 mg | Film-coated tablet · Oral use | 28 Blister | SAR 11.30 | Generic · Prescription | National Pharmaceutical Industries Co. (SAOG) | Valid |
| Betaten | 100 mg | Film-coated tablet · Oral use | 840 Blister | SAR 485.60 | Generic · Prescription | National Pharmaceutical Industries Co. (SAOG) | Valid |
| Betaten | 50 mg | Film-coated tablet · Oral use | 840 Blister | SAR 242.80 | Generic · Prescription | National Pharmaceutical Industries Co. (SAOG) | Valid |
| NORMOTEN 100 MG F.C TAB | 100 mg | Tablet · Oral use | 28 Blister | SAR 19.25 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| NORMOTEN 100 MG F.C TAB | 100 mg | Tablet · Oral use | 14 Blister | SAR 9.60 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| NORMOTEN 50 MG F.C. TAB | 50 mg | Tablet · Oral use | 28 Blister | SAR 18.65 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Normoten | 50 mg | Film-coated tablet · Oral use | 210 Blister | SAR 139.85 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| Normoten | 100 mg | Film-coated tablet · Oral use | 182 Blister | SAR 125.10 | Generic · Prescription | Jazeera Pharmaceutical Industries (JPI) | Valid |
| TENORMIN TAB 100MG | 100 mg | Film-coated tablet · Oral use | 28 Blister | SAR 19.25 | NCE · Prescription | Atnahs Pharma UK Limited | Valid |
| TENORMIN TAB 100MG | 100 mg | Film-coated tablet · Oral use | 14 Blister | SAR 9.60 | NCE · Prescription | Atnahs Pharma UK Limited | Valid |
| TENORMIN TAB 50MG | 50 mg | Film-coated tablet · Oral use | 28 Blister | SAR 18.65 | NCE · Prescription | Atnahs Pharma UK Limited | Valid |
| TENSOTIN 100 MG TAB | 100 mg | Film-coated tablet · Oral use | 30 Blister | SAR 20.60 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| ATORMIN 100MG TABLETS | 100 mg | Tablet · Oral use | 28 Blister | SAR 16.65 | Generic · Prescription | OMAN PHARMACEUTICAL PRODUCTS | Withdrawn by MAH · Not Marketed |
| ATORMIN 50MG TABLETS | 50 mg | Tablet · Oral use | 28 Blister | SAR 9.80 | Generic · Prescription | OMAN PHARMACEUTICAL PRODUCTS | Withdrawn by MAH · Not Marketed |
| BLOKIUM TAB 100MG | 100 mg | Tablet · Oral use | 15 Blister | SAR 20.75 | Generic · Prescription | ALMIRALL PRODES PHARMA S.A. | Withdrawn by MAH · Not Marketed |
| CANAR 100 MG TABLET | 100 mg | Tablet · Oral use | 28 Blister | SAR 29.55 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| CANAR 50 MG TABLET | 50 mg | Tablet · Oral use | 28 Blister | SAR 18.45 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Withdrawn by MAH · Not Marketed |
| CARDOL 100MG TAB | 100 mg | Tablet · Oral use | 20 Blister | SAR 27.50 | Generic · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| GLORMIN 100MG TABLET | 100 mg | Tablet · Oral use | 28 Blister | SAR 21.50 | Generic · Prescription | GLOBAL PHARMA | Withdrawn by MAH · Not Marketed |
| GLORMIN 25MG TABLET | 25 mg | Tablet · Oral use | 28 Blister | SAR 7.40 | Generic · Prescription | GLOBAL PHARMA | Withdrawn by MAH · Not Marketed |
| GLORMIN 50MG TABLET | 50 mg | Tablet · Oral use | 28 Blister | SAR 12.55 | Generic · Prescription | GLOBAL PHARMA | Withdrawn by MAH · Not Marketed |
| HYPOTEN 100 TAB | 100 mg | Tablet · Oral use | 14 Blister | SAR 21.55 | Generic · Prescription | Hikma Pharmaceuticals PLC | Withdrawn by MAH · Not Marketed |
| HYPOTEN 50 TAB | 50 mg | Tablet · Oral use | 28 Blister | SAR 22.40 | Generic · Prescription | Hikma Pharmaceuticals PLC | Withdrawn by MAH · Not Marketed |
14 more — full table
Indications — CHI Daman Drug Formulary
ARRHYTHMIA; ATRIAL FIBRILLATION; CORONARY ARTERY DISEASE; HYPERTENSION; HYPERTHYROIDISM; INFANTILE HEMANGIOMA; MIGRAINE/ HEADACHE; NON-ST WAVE ELEVATED MYOCARDIAL INFARCTION (NSTEMI); ST-WAVE ELEVATED MYOCARDIAL INFARCTION (STEMI); SUPRAVENTRICULAR TACHYCARDIA; VENTRICULAR TACHYCARDIA
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| TENORMIN | 50MG; 100MG; 25MG | tablet · oral | TWI PHARMS | Prescription | 19 Aug 1981 |
| ATENOLOL | 100MG; 25MG; 50MG | tablet · oral | AIPING PHARM INC | Prescription | 15 Jul 1988 |
| ATENOLOL | 100MG; 25MG; 50MG | tablet · oral | PHARMOBEDIENT | Prescription | 17 Sep 1991 |
| ATENOLOL | 100MG; 25MG; 50MG | tablet · oral | MYLAN | Prescription | 24 Jan 1992 |
| ATENOLOL | 50MG; 100MG; 25MG | tablet · oral | TEVA | Prescription | 18 Jan 1995 |
| ATENOLOL | 25MG; 50MG; 100MG | tablet · oral | ZYDUS PHARMS USA | Prescription | 28 Jan 2005 |
| ATENOLOL | 25MG; 50MG; 100MG | tablet · oral | UNIQUE | Prescription | 13 Sep 2006 |
| ATENOLOL | 25MG; 50MG; 100MG | tablet · oral | IPCA LABS LTD | Prescription | 27 Dec 2006 |
| ATENOLOL | 25MG; 50MG; 100MG | tablet · oral | AUROBINDO PHARMA | Prescription | 31 Oct 2007 |
| ATENOLOL | 25MG; 50MG; 100MG | tablet · oral | UNICHEM | Prescription | 21 Nov 2019 |
| TENORMIN | 0.5MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | injectable · injection | ASTRAZENECA | Discontinued | 13 Sep 1989 |
| ATENOLOL | 50MG | tablet · oral | NOVITIUM PHARMA | Discontinued | 19 Dec 1991 |
| ATENOLOL | 100MG | tablet · oral | NOVITIUM PHARMA | Discontinued | 19 Dec 1991 |
| ATENOLOL | 50MG | tablet · oral | WATSON LABS | Discontinued | 27 Dec 1991 |
| ATENOLOL | 100MG | tablet · oral | WATSON LABS TEVA | Discontinued | 27 Dec 1991 |
| ATENOLOL | 25MG | tablet · oral | NOVITIUM PHARMA | Discontinued | 28 Apr 1992 |
| ATENOLOL | 50MG; 100MG | tablet · oral | SCS | Discontinued | 30 Oct 1992 |
| ATENOLOL | 50MG | tablet · oral | SUN PHARM INDUSTRIES | Discontinued | 30 Mar 1993 |
| ATENOLOL | 100MG | tablet · oral | SUN PHARM INDUSTRIES | Discontinued | 30 Mar 1993 |
| ATENOLOL | 50MG | tablet · oral | TEVA | Discontinued | 28 May 1993 |
| ATENOLOL | 100MG | tablet · oral | TEVA | Discontinued | 28 May 1993 |
| ATENOLOL | 25MG; 50MG; 100MG | tablet · oral | CHARTWELL RX | Discontinued | 28 Feb 1994 |
| ATENOLOL | 50MG; 100MG; 25MG | tablet · oral | MYLAN | Discontinued | 23 Mar 1994 |
| ATENOLOL | 50MG; 100MG | tablet · oral | NOSTRUM LABS | Discontinued | 21 Feb 1995 |
| ATENOLOL | 50MG; 100MG | tablet · oral | TEVA PHARMS | Discontinued | 24 Feb 1995 |
7 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-ATENOL TAB 100MG | 00773697 | 100 MG | TABLET · ORAL | APOTEX INC |
| APO-ATENOL TAB 50MG | 00773689 | 50 MG | TABLET · ORAL | APOTEX INC |
| ATENOLOL | 02238316 | 50 MG | TABLET · ORAL | SIVEM PHARMACEUTICALS ULC |
| ATENOLOL | 02238318 | 100 MG | TABLET · ORAL | SIVEM PHARMACEUTICALS ULC |
| ATENOLOL | 02541564 | 25 MG | TABLET · ORAL | SIVEM PHARMACEUTICALS ULC |
| JAMP-ATENOLOL | 02367556 | 25 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP-ATENOLOL | 02367564 | 50 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| JAMP-ATENOLOL | 02367572 | 100 MG | TABLET · ORAL | JAMP PHARMA CORPORATION |
| MAR-ATENOLOL | 02371979 | 25 MG | TABLET · ORAL | MARCAN PHARMACEUTICALS INC |
| MAR-ATENOLOL | 02371987 | 50 MG | TABLET · ORAL | MARCAN PHARMACEUTICALS INC |
| MAR-ATENOLOL | 02371995 | 100 MG | TABLET · ORAL | MARCAN PHARMACEUTICALS INC |
| MINT-ATENOL | 02368013 | 25 MG | TABLET · ORAL | MINT PHARMACEUTICALS INC |
| MINT-ATENOL | 02368021 | 50 MG | TABLET · ORAL | MINT PHARMACEUTICALS INC |
| MINT-ATENOL | 02368048 | 100 MG | TABLET · ORAL | MINT PHARMACEUTICALS INC |
| PMS-ATENOLOL | 02237600 | 50 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-ATENOLOL | 02237601 | 100 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PMS-ATENOLOL | 02246581 | 25 MG | TABLET · ORAL | PHARMASCIENCE INC |
| PRO-ATENOLOL | 00828793 | 100 MG | TABLET · ORAL | PRO DOC LIMITEE |
| PRO-ATENOLOL | 00828807 | 50 MG | TABLET · ORAL | PRO DOC LIMITEE |
| PRO-ATENOLOL | 02326701 | 25 MG | TABLET · ORAL | PRO DOC LIMITEE |
| TARO-ATENOLOL | 02267985 | 50 MG | TABLET · ORAL | SUN PHARMA CANADA INC |
| TARO-ATENOLOL | 02267993 | 100 MG | TABLET · ORAL | SUN PHARMA CANADA INC |
| TARO-ATENOLOL | 02373963 | 25 MG | TABLET · ORAL | SUN PHARMA CANADA INC |
| TENORMIN | 02039532 | 50 MG | TABLET · ORAL | SEARCHLIGHT PHARMA INC |
| TENORMIN | 02039540 | 100 MG | TABLET · ORAL | SEARCHLIGHT PHARMA INC |
3 more — full table
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | ATENOLOL 100 MG TABLET | $0.03614 | per EA | 23 Sep 2026 |
| US NADAC | ATENOLOL 25 MG TABLET | $0.02171 | per EA | 30 Sep 2026 |
| US NADAC | ATENOLOL 50 MG TABLET | $0.0236 | per EA | 30 Sep 2026 |
| US NADAC | TENORMIN 50 MG TABLET | $12.7821 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Atenolol 100mg tablets | £0.80 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Atenolol 25mg tablets | £0.66 | 28 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Atenolol 25mg/5ml oral solution sugar free | £5.37 | 300 ml | 1 Oct 2026 |
| NHS Drug Tariff | Atenolol 50mg tablets | £0.70 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 12.3. Antihypertensive medicines · core
Therapeutic equivalent to bisoprolol for Essential hypertension
Safety signals and safety-related labeling changes
- US FDA 22 Dec 2023 TENORETIC 100 — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Patient Counseling Information / Patient Information / Medication Guide - US FDA 22 Dec 2023 TENORETIC 50 — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Patient Counseling Information / Patient Information / Medication Guide - US FDA 22 Dec 2023 TENORMIN — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Patient Counseling Information / Patient Information / Medication Guide
Combinations containing Atenolol
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.